Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Assets (2016 - 2026)

Cytosorbents filings provide 14 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q4 2025 for Cytosorbents, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2024 to a low of 0.01% in Q3 2022.
  • Median Return on Assets over the past 5 years was 0.0% (2021), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Assets: changed 0bps in 2021 and later rose 1bps in 2024.
  • Cytosorbents' Return on Assets stood at 0.0% in 2021, then tumbled by -97bps to 0.01% in 2022, then skyrocketed by 72bps to 0.0% in 2023, then dropped by -27bps to 0.0% in 2024, then crashed by -84bps to 0.0% in 2025.
  • The last three reported values for Return on Assets were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.